Clinical Trial Update: Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adults, Adolescents, Children, and Toddlers in India and Healthy Adolescents and Children in the Republic of South Africa [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the immunogenicity and safety of an investigational quadrivalent meningococcal conjugate vaccine in healthy adults, adolescents, chil…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Disease

Drugs mentioned

• Investigational quadrivalent meningococcal conjugate vaccine

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Meningococcal Immunization, Healthy Volunteers | Phase 3 | Status: COMPLETED | Results posted: 2025-02-03